|
Q3 2024
|
137 |
434,197 |
ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, EQUINOX GOLD CORP, REVANCE THERAPEUTICS INC
|
13F-HR
|
11/14/2024 |
000170616424000007 |
|
Q2 2024
|
126 |
363,886 |
ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, BANDWIDTH INC, SSR MINING IN
|
13F-HR
|
8/14/2024 |
000170616424000003 |
|
Q1 2024
|
116 |
378,180 |
ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, BANDWIDTH INC, SSR MINING IN
|
13F-HR
|
5/15/2024 |
000170616424000002 |
|
Q4 2023
|
105 |
306,776 |
ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, SSR MINING IN, OPKO HEALTH INC
|
13F-HR
|
2/14/2024 |
000170616424000001 |
|
Q3 2023
|
112 |
333,695 |
ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, OPKO HEALTH INC, BANDWIDTH INC
|
13F-HR
|
11/14/2023 |
000170616423000004 |
|
Q2 2023
|
114 |
321,680 |
BANDWIDTH INC, ESPERION THERAPEUTICS INC NE, OPKO HEALTH INC, FIRST MAJESTIC SILVER CORP
|
13F-HR
|
8/10/2023 |
000170616423000003 |
|
Q1 2023
|
130 |
318,441 |
FIRST MAJESTIC SILVER CORP, OPKO HEALTH INC, PARATEK PHARMACEUTICALS INC, BANDWIDTH INC
|
13F-HR
|
5/15/2023 |
000170616423000002 |
|
Q4 2022
|
140 |
335,435 |
FORUM ENERGY TECHNOLOGIES IN, PARATEK PHARMACEUTICALS INC, OPKO HEALTH INC, ESPERION THERAPEUTICS INC NE
|
13F-HR
|
2/10/2023 |
000170616423000001 |
|
Q3 2022
|
179 |
319,685 |
ESPERION THERAPEUTICS INC NE, FORUM ENERGY TECHNOLOGIES IN, PARATEK PHARMACEUTICALS INC, OPKO HEALTH INC
|
13F-HR
|
11/14/2022 |
000170616422000004 |
|
Q2 2022
|
179 |
361,688 |
ESPERION THERAPEUTICS INC NE, FORUM ENERGY TECHNOLOGIES IN, PRECIGEN INC, PARATEK PHARMACEUTICALS INC
|
13F-HR
|
8/15/2022 |
000170616422000003 |
|
Q1 2022
|
172 |
408,318 |
SANGOMA TECHNOLOGIES CORP, PARATEK PHARMACEUTICALS INC, PRECIGEN INC, ESPERION THERAPEUTICS INC NE
|
13F-HR
|
5/17/2022 |
000170616422000002 |
|
Q4 2021
|
157 |
440,535 |
SANGOMA TECHNOLOGIES CORP COM, PARATEK PHARMACEUTICALS INC, PRECIGEN INC, SFIX
|
13F-HR
|
2/15/2022 |
000170616422000001 |
|
Q3 2021
|
140 |
382,691 |
PARATEK PHARMACEUTICALS INC, BUR.L, INTREXON CORP, TRICIDA INC
|
13F-HR
|
11/15/2021 |
000170616421000006 |
|
Q2 2021
|
88 |
427,168 |
PARATEK PHARMACEUTICALS INC, BUR.L, INTERCEPT PHARMACEUTICALS IN, Z
|
13F-HR
|
8/13/2021 |
000170616421000005 |
|
Q1 2021
|
92 |
411,798 |
PARATEK PHARMACEUTICALS INC, BUR.L, INTERCEPT PHARMACEUTICALS IN, SSNC
|
13F-HR
|
5/10/2021 |
000170616421000004 |
|
Q4 2020
|
81 |
393,371 |
PARATEK PHARMACEUTICALS INC, FIRST MAJESTIC SILVER CORP, BUR.L, BIDU
|
13F-HR
|
2/12/2021 |
000170616421000003 |
|
Q3 2020
|
70 |
359,603 |
SUNPOWER CORP, PARATEK PHARMACEUTICALS INC, JENGQ, TWITTER INC
|
13F-HR
|
11/16/2020 |
000170616420000004 |
|
Q2 2020
|
71 |
369,964 |
SUNPOWER CORP, PARATEK PHARMACEUTICALS INC, EGAN, TWITTER INC
|
13F-HR
|
8/17/2020 |
000170616420000003 |
|
Q1 2020
|
57 |
320,386 |
SUNPOWER CORP, TWITTER INC, PARATEK PHARMACEUTICALS INC, AVAYA HLDGS CORP
|
13F-HR
|
4/27/2020 |
000170616420000002 |
|
Q4 2019
|
55 |
356,325 |
SUNPOWER CORP, SSNC, HHC, KKR
|
13F-HR
|
2/5/2020 |
000170616420000001 |
|
Q3 2019
|
64 |
297,251 |
SUNPOWER CORP, AVAYA HLDGS CORP, KKR, SSNC
|
13F-HR
|
10/29/2019 |
000170616419000007 |
|
Q2 2019
|
67 |
280,132 |
KKR, HHC, SUNPOWER CORP, SSNC
|
RESTATEMENT
|
7/31/2019 |
000170616419000005 |
|
Q1 2019
|
69 |
343,893 |
SUNPOWER CORP, KKR, HHC, SSNC
|
13F-HR
|
4/23/2019 |
000170616419000002 |
|
Q4 2018
|
70 |
302,439 |
MIDD, ESI, KKR, SSNC
|
13F-HR
|
1/24/2019 |
000170616419000001 |
|
Q3 2018
|
69 |
322,057 |
BIDU, HHC, LILA, CFX
|
13F-HR
|
10/17/2018 |
000170616418000005 |
|
Q2 2018
|
63 |
285,980 |
BIDU, ESI, HHC, SW.TO
|
13F-HR
|
7/17/2018 |
000170616418000004 |
|
Q1 2018
|
71 |
240,142 |
KW, ESI, SW.TO, HHC
|
13F-HR
|
5/4/2018 |
000170616418000002 |
|
Q4 2017
|
35 |
152,406 |
BIDU, LILA, TRIP, CFX
|
13F-HR
|
2/6/2018 |
000170616418000001 |